A drug dose model for predicting clinical outcomes in hypertensive coronary disease patients
{{output}}
To understand the effects of single- and multiple-drug combinations for hypertension on the risk of adverse clinical outcomes, the authors analyzed data from the International Verapamil SR/Trandolapril Study (INVEST). This trial randomized 22,576 hypertensive ... ...
